Hostname: page-component-745bb68f8f-mzp66 Total loading time: 0 Render date: 2025-02-12T07:26:44.019Z Has data issue: false hasContentIssue false
  • English
  • Français

Psychosis in Parkinson's Disease: Phenomenology, Frequency, Risk Factors, and Current Understanding of Pathophysiologic Mechanisms

Published online by Cambridge University Press:  07 November 2014

Gilles Fénelon
Get access Rights & Permissions [Opens in a new window]

Abstract

Psychosis in Parkinson's disease refers to a combination of hallucinations and delusions occurring with a clear sensorium and a chronic course. Hallucinations may involve several sensory modalities. Complex visual hallucinations are the most common type. “Minor” hallucinatory phenomena are frequently present and include visual illusions, passage hallucinations, and sense of presence. Insight may be lost in patients with cognitive impairment. Delusions of a paranoid type are more rare than hallucinations. Both hallucinations and delusions are more frequent in Parkinson's disease patients with dementia. Pathogenesis involves complex and probably multifactorial mechanisms, including pharmacologic (dopaminergic treatment and others) and disease-related factors.

Type
Supplement
Information
CNS Spectrums , Volume 13 , Issue S4: Neuropsychiatric Aspects of Parkinson's Disease: Focus on Insomnia, Daytime Sleepiness, and Psychosis , March 2008 , pp. 18 - 25
Copyright
Copyright © Cambridge University Press 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1.Ravina, B, Marder, K, Fernandez, HH, et al.Diagnostic Criteria for Psychosis in Parkinson's disease: Report of an NINDS/NIMH Work Group. Mov Disord. 2007;22(8):1061–1068.CrossRefGoogle ScholarPubMed
2.Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.Google Scholar
3.Fernandez, HH, Aarsland, D, Fénelon, G, et al.Scales to Assess psychosis in Parkinson's disease: Critique and recommendations. Mov Disord. 2008. In press.Google Scholar
4.Fénelon, G, Mahieux, F, Huon, R, Ziégler, M. Hallucinations in Parkinson's disease. Prevalence, phenomenology and risk factors. Brain. 2000;123(Pt 4):733–745.CrossRefGoogle ScholarPubMed
5.Barnes, J, David, AS. Visual hallucinations in Parkinson's disease: a review and phenomenological survey. J Neurol Neurosurg Psychiatry. 2001;70(6):727–733.CrossRefGoogle ScholarPubMed
6.Holroyd, S, Currie, L, Wooten, GF. Prospective study of hallucinations and delusions in Parkinson's disease. J Neurol Neurosurg Psychiatry. 2001:70(6):734–738.Google Scholar
7.Mosimann, UP, Rowan, EN, Partington, CE, et al.Characteristics of visual hallucinations in Parkinson's disease dementia and dementia with Lewy bodies. Am J Geriatr Psychiatry. 2006;14(2):153–160.Google Scholar
8.Inzelberg, R, Kipervasser, S, Korczyn, AD. Auditory hallucinations in Parkinson's disease. J Neurol Neurosurg Psychiatry. 1998;64(4):533–535.CrossRefGoogle ScholarPubMed
9.Fénelon, G, Thobois, S, Bonnet, AM, Broussolle, E, Tison, F. Tactile hallucinations in Parkinson's disease. J Neurol. 2002;249(12):1699–1703.CrossRefGoogle ScholarPubMed
10.Tousi, B, Frankel, M. Olfactory and visual hallucinations in Parkinson's disease. Parkinsonism Relat Dis. 2004;10(4):253–254.Google Scholar
11.Goetz, CG, Wuu, J, Curgian, L, Leurgans, S. Age-related influences on the clinical characteristics of new-onset hallucinations in Parkinson's disease patients. Mov Disord. 2006;21(2):267–270.Google Scholar
12.Williams, DR, Warren, JD, Lees, AJ. Using the presence of visual hallucinations to differentiate Parkinson's disease from atypical Parkinsonism. J Neurol Neurosurg Psychiatry. 2007. In press.Google Scholar
13.Ebersbach, G. An artist's view of drug-induced hallucinosis. Mov Disord. 2003;18(7):833–834.Google Scholar
14.Fernandez, W, Stern, G, Lees, AJ. Hallucinations and parkinsonian motor fluctuations. Behav Neurol. 1992;5:83–86.Google Scholar
15.Marsh, L, Williams, JR, Rocco, M, Grill, S, Munro, C, Dawson, TM. Psychiatric comorbidities in patients with Parkinson disease and psychosis. Neurology. 2004;63(2):293–300.Google Scholar
16.Kiziltan, G, Ôzekmekçi, S, Ertan, S, Ertan, T, Erginöz, E. Relationship between age and subtypes of psychotic symptoms in Parkinson's disease. J Neurol. 2007;254(4):448–452.Google Scholar
17.Sanchez-Ramos, JR, Ortoll, R, Paulson, GW. Visual hallucinations associated with Parkinson's disease. Arch Neurol. 1996;53(12):1265–1268.Google Scholar
18.Graham, JM, Grünewald, RA, Sagar, HJ. Hallucinosis in idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry. 1997;63(4):434–440.Google Scholar
19.Bailbé, M, Karolewicz, S, Neau, JP, et al.Hallucinations, idées délirantes, événement nocturnes chez 152 patients atteints de maladie de Parkinson. Rev Neurol (Paris). 2002;158(2):203–210.Google Scholar
20.Aarsland, D, Larsen, JP, Cummins, JL, Laake, K. Prevalence and clinical correlates of psychotic symptoms in Parkinson disease: a community-based study. Arch Neurol. 1999;56(5):595–601.Google Scholar
21.Schrag, A, Ben-Shlomo, Y, Quinn, N. How common are complications of Parkinson's disease. J Neurol. 2002;249(4):419–423.Google Scholar
22.Paleacu, D, Schechtman, E, Inzelberg, R. Association between family history of dementia and hallucinations in Parkinson disease. Neurology. 2005;64(10):1712–1715.Google Scholar
23.Pacchetti, C, Manni, R, Zangaglia, R, et al.Relationship between hallucinations, delusions and REM behavior disorder in Parkinson's disease. Mov Disord. 2005;20(11):1439–1448.CrossRefGoogle ScholarPubMed
24.Chou, KL, Messing, S, Oakes, D, Feldman, PD, Breier, A, Friedman, JH. Drug-induced psychosis in Parkinson disease: phenomenology and correlations among psychosis rating instruments. Clin Neuropharmacol. 2005;28(1):215–219.Google Scholar
25.Williams, DR, Lees, AJ. Visual hallucinations in the diagnosis of idiopathic Parkinson's disease: a retrospective autopsy study. Lancet Neurol. 2005;4(10):605–610.Google Scholar
26.Aarsland, D, Ballard, C, Larsen, JP, McKeith, I. A comparative study of psychiatric symptoms in dementia with Lewy bodies and Parkinson's disease with and without dementia. Int J Geriatr Psychiatry. 2001;16(5):528–536.Google Scholar
27.Galvin, JE, Pollack, J, Morris, JC. Clinical phenotype of Parkinson disease dementia. Neurology. 2006;67(9):1605–1611.CrossRefGoogle ScholarPubMed
28.Aarsland, D, Bronnick, K, Ehrt, U, et al.Neuropsychiatric symptoms in patients with Parkinson's disease and dementia: frequency, profile and associated care giver stress. J Neurol Neurosurg Psychiatry. 2007;78(1):36–42.CrossRefGoogle ScholarPubMed
29.Kitayama, M, Wada-Isoe, K, Nakaso, K, Irizawa, Y, Nakashima, K. Clinical evaluation of Parkinson's disease dementia: association with againg and visual hallucinations. Acta Neurol Scand. 2007;116(3):190–195.CrossRefGoogle Scholar
30.Papapetropoulos, S, Mash, DC. Psychotic symptoms in Parkinson's disease. From description to etiology. J Neurol. 2005;252(7):753–764.Google Scholar
31.Goetz, CG, Pappert, EJ, Blasucci, LM, et al.Intravenous levodopa infusions inhallucinationg Parkinson's disease patients: high-dose challenge does not precipitate hallucinations. Neurology. 1998;50(2):515–517.Google Scholar
32.Fénelon, G, Goetz, CG, Karenberg, A. Hallucinations in the prelovodopa era in Parkinson's disease. Neurology. 2006,66(1):93–98.Google Scholar
33.Biousse, V, Skibell, BC, Watts, RL, et al.Ophthalmologic features of Parkinson's disease. Neurology. 2004;62(2):177–180.Google Scholar
34.Tiraboschi, P, Salmon, DP, Hansen, LA, Hofstetter, RC, Thal, LJ, Corey-Bloom, J. What best differentiates Lewy body from Alzheimer's disease in early-stage dementia. Brain. 2006;129(Pt 3):729–735.Google Scholar
35.Giladi, N, Treves, A, Paleacu, D, et al.Risk factors for dementia, depression, and psychosis in long-standing Parkinson's disease. J Neural Transm. 2000;107(1):59–71.Google Scholar
36.Biglan, KM, Holloway, RG, McDermott, MP, Richard, IH, Parkinson Study Group CALMPD Investigators. Risk factors for somnolence, edema, and hallucinations in early Parkinson disease. Neurology. 2007;69(2):187–195.Google Scholar
37.Barnes, J, Boubert, L, Harris, J, Lee, A, David, AS. Reality monitoring and visual hallucinations in Parkinson's disease. Neuropsychologia. 2003;41(5):565–574.Google Scholar
38.Mosimann, UP, Mather, G, Wesnes, KA, O'Brien, JT, Burn, DJ, McKeith, IG. Visual perception in Parkinson disease dementia and dementia with Lewy bodies. Neurology. 2004;63(11):2091–2096.Google Scholar
39.Ramírez-Ruiz, B, Junqué, C, Martí, MJ, Valldeoriola, F, Tolosa, E. Neuropsychological deficits in Parkinson's disease patients with visual hallucinations. Mov Disord. 2006;21(9):1483–1487.Google Scholar
40.Grossi, D, Trojano, L, Pellecchia, MT, Amboni, M, Fragassi, NA, Barone, P. Frontal dys-function contributes to the genesis of hallucinations in non-demented parkinsonian patients. Int J Geriatr Psychiatry. 2005;20(7):668–673.Google Scholar
41.Sinforiani, E, Zangaglia, R, Manni, R, et al.REM sleep behavior disorder, hallucinations, and cognitive impairment in Parkinson's disease. Mov Disord. 2006;21(4):462–466.CrossRefGoogle ScholarPubMed
42.Moskovitz, C, Moses, H 3rd, Klawans, HL. Levodopa-induced psychosis: a kindling phenomenon. Am J Psychiatry. 1978;135(6):669–675.Google Scholar
43.Nausieda, PA, Weiner, WJ, Kaplan, LR, Weber, S, Klawans, HL. Sleep disruption in the course of chronic levodopa therapy: an early feature of the levodopa psychosis. Clin Neuropharmacol. 1982;5(2): 183–194.Google Scholar
44.Pappert, EJ, Goetz, CG, Niederman, FG, Raman, R, Leurgans, S. Hallucinations, sleep fragmentation, and altered dream phenomena in Parkinson's disease. Mov Disord. 1999;14(1):117–121.Google Scholar
45.Goetz, CG, Wuu, J, Curgian, LM, Leurgans, S. Hallucinations and sleep disorders in PD. Six-year prospective longitudinal study. Neurology. 2005;64(1):81–86.Google Scholar
46.Comella, CL, Tanner, CM, Ristanovic, RK. Polysomnographic sleep measures in Parkinson's disease patients with treatment-induced hallucinations. Ann Neurol. 1993;34(5):710–714.Google Scholar
47.Arnulf, I, Bonnet, A-M, Damier, P, et al.Hallucinations, REM sleep, and Parkinson's disease: a medical hypothesis. Neurology. 2000;55(2):281–288.Google Scholar
48.Manni, R, Pacchetti, C, Terzaghi, M, et al.Hallucinations and sleep-wake cycle in PD: a 24-hour continuous polysomnographic study. Neurology. 2002;59(12):1979–1981.Google Scholar
49.Nomura, T, Inoue, Y, Mitani, H, Kawahara, R, Miyake, M, Nakashima, K. Visual hallucinations as REM sleep behavior disorders in patients with Parkinson's disease. Mov Disord. 2003;18(7):812–817.Google Scholar
50.Onofrj, M, Bonanni, L, Albani, G, Mauro, A, Bulla, D, Thomas, A. Visual hallucinations in Parkinson's disease: clues to separate origins. J Neurol Sci. 2006;248(1–2):143–150.Google Scholar
51.Teunisse, RJ, Cruysberg, JR, Hoefnagels, WH, Verbeek, AL, Zitman, FG. Visual hallucinations in psychologically normal people: Charles Bonnet's syndrome. Lancet. 1996;347(9004):794–797.Google Scholar
52.Holroyd, S, Sheldon-Keller, A. A study of visual hallucinations in Alzheimer's disease. J Am Ger Soc.1995;3:198–205.Google Scholar
53.Matsui, H, Udaka, F, Tamura, A, et al.Impaired visual acuity as a risk factor for visual hallucinations in Parkinson's disease. J Geriatr Psychiatry Neurol. 2006;19(1):36–40.CrossRefGoogle ScholarPubMed
54.Diederich, NJ, Raman, R, Leurgans, S, Goetz, CG. Progressive worsening of spatial and chromatic processing deficits in Parkinson disease. Arch Neurol. 2002;59(8):1249–1252.Google Scholar
55.Diederich, NJ, Goetz, CG, Raman, R, Pappert, EJ, Leurgans, S, Piery, V. Poor visual discrimination and visual hallucinations in Parkinson's disease. Clin Neuropharmacol. 1998;21(5):289–295.Google ScholarPubMed
56.Okada, K, Suyama, N, Oguro, H, Yamaguchi, S, Kobayashi, S. Medication-induced hallucinations and cerebral blood flow in Parkinson's disease. J Neurol. 1999;246(5):365–368.Google Scholar
57.Nagano-Saito, A, Washimi, Y, Arahata, Y, et al.Visual hallucinations in Parkinson's disease with FDG PET. Mov Disord. 2004;19(7):801–806.Google Scholar
58.Oishi, N, Udaka, F, Kameyama, M, Sawamoto, N, Hashikawa, K, Fukuyama, H. Regional cerebral blood flow in Parkinson disease with nonpsychotic visual hallucinations. Neurology. 2005;65(11):1708–1715.Google Scholar
59.Matsui, H, Nishinaka, K, Oda, M, et al.Hypoperfusion of the visual pathway in parkinsonian patients with visual hallucinations. Mov Disord. 2006;21(12):2140–2144.Google Scholar
60.Boecker, H, Ceballos-Baumann, AO, Volk, D, Conrad, B, Forstl, H, Haussermann, P. Metabolic alterations in patients with Parkinson disease and visual hallucinations. Arch Neurol. 2007;64(7):984–988.Google Scholar
61.Stebbins, GT, Goetz, CG, Carrillo, MC, et al.Altered cortical visual processing in PD with hallucinations: an fMRI study. Neurology. 2004;63(8):1409–1416.Google Scholar
62.Harding, AJ, Broe, GA, Halliday, GM. Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe. Brain. 2002;125(Pt 2):391–403.Google Scholar
63.Papapetropoulos, S, McCorquodale, DS, Gonzalez, J, Jean-Gilles, L, Mash, DC. Cortical and amygdalar Lewy body burden in Parkinson's disease patients with visual hallucinations. Parkinsonism Relat Disord. 2006;12(4):253–256.Google Scholar
64.Diederich, NJ, Goetz, CG, Stebbins, GT. Repeated visual hallucinations in Parkinson's disease as disturbed external/internal perceptions: focused review and a new integrative model. Mov Disord. 2005:20(2):130–140.Google Scholar
65.Wolters, EC. Intrinsic and extrinsic psychosis in Parkinson's disease. J Neurol. 2001;248(suppl 3):22–27.Google Scholar
66.Birkmayer, W, Riederer, P. Responsibility of extrastriatal areas for the appearance of psychotic symptoms (clinical and biochemical human post-mortem findings). J Neural Transm. 1975;37(2):175–182.Google Scholar
67.Perry, EK, Marshall, E, Kerwin, J, et al.Evidence of a monoaminergic-cholinergic imbalance related to visual hallucinations in Lewy body dementia. J Neurochem. 1990;55(4):1454–1456.Google Scholar
68.Perry, EK, Perry, RH. Acetylcholine and hallucinations: disease-related compared to drug-induced alterations in human consciousness. Brain Cogn. 1995;28(3):240–258.Google Scholar
69.Francis, PT, Perry, EK. Cholinergic and other neurotransmitter mechanisms in Parkinson's disease. Parkinson's disease dementia, and dementia with Lewy bodies. Mov Disord. 2007;22(suppl 17):351–357.Google Scholar
70.Makoff, AJ, Graham, JM, Arranz, MJ, et al.Association study of dopamine receptor gene polymorphisms with drug-induced hallucinations in patients with idiopathic Parkinson's disease. Pharmacogenetics. 2000;10(1):43–48.Google Scholar
71.Goetz, CG, Burke, PF, Leurgans, S, et al.Genetic variation analysis in Parkinson disease patients with and without hallucinations: case-control study. Arch Neurol. 2001;58(2):209–213.Google Scholar
72.Wang, J, Zhao, C, Chen, B, Liu, ZL. Polymorphisms of dopamine receptor and transporter genes and hallucinations in Parkinson's disease. Neurosci Lett. 2004;355(3):193–196.Google Scholar
73.Wang, J, Si, Y-M, Liu, ZL, Yu, L. Cholecystokinin, cholecystokinin-A receptor and cholecystokinin-B receptor gene polymorphisms in Parkinson's disease. Pharmacogenetics. 2003;13(6):365–369.Google Scholar
74.Goldman, JG, Goetz, CG, Berry-Kravis, E, Leurgans, S, Zhou, L. Genetic polymorphisms in Parkinson Disease subjects with and without hallucinations. Arch Neurol. 2004;61(8):1280–1284.Google Scholar
75.Kiferle, L, Ceravolo, R, Petrozzi, L, et al.Visual hallucinations in Parkinson's disease are not influenced by polymorphisms of serotonin 5-HT2A receptor and transporter genes. Neurosci Lett. 2007;422(3):228–231.Google Scholar
76.ffytche, DH, Howard, RJ, Brammer, MJ, David, A, Woodruff, P, Williams, S. The anatomy of conscious vision: an fMRI syudy of visual hallucinations. Nature Neurosci. 1998;1(8):738–742.Google Scholar
77.Collerton, D, Perry, E, McKeith, I. Why people see things that are not there: a novel Perception and Attention Deficit model for recurrent complex visual hallucinations. Behav Brain Sci. 2005;28(6):737–757.CrossRefGoogle ScholarPubMed